Management of congenital subglottic hemangioma

Charles Anthony Hughes, Ali Rezaee, Jeffrey P. Ludemann, Lauren D. Holinger

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: This study was conducted to assess the safety and efficacy of individualized management of congenital subglottic hemangioma (CSH) at the Children's Memorial Hospital in Chicago; describe treatment modalities, including endoscopic excision with the carbon dioxide (CO2) laser, systemic corticosteroids, and intralesional corticosteroid injection with short-term intubation; and determine the success of these various strategies in avoiding tracheotomy. Methods: During the 10-year period between January 1, 1988 and December 31, 1997, 28 infants were diagnosed with CSH. A retrospective review of medical records was undertaken to determine demographics, presenting symptoms, location of the lesion, therapeutic modality, and complications. All patients were contacted at the time of writing. Results: Twenty-eight patients met the criteria for this study. Gender distribution was 1.8:1 female to male. Age at diagnosis ranged from 4 weeks to 8 months, with a mean of 78.8 days and a median of 60 days. The location of CSH was most often posterior and on the left. Associated hemangiomas were found in 14 (50%) cases. The most common symptoms were stridor and cough. Management included 1 to 13 operative direct laryngoscopies and bronchoscopies, endoscopic excision with the (CO2) laser, and the use of systemic and intralesional corticosteroids. No patient required tracheotomy. Conclusion: Morbidity and the need for tracheotomy in CSH patients can be minimized using a combination of therapeutic modalities. Each infant's treatment is individualized based on the severity of the patient's symptoms and the morphology of the lesion.

Original languageEnglish (US)
Pages (from-to)223-228
Number of pages6
JournalJournal of Otolaryngology
Volume28
Issue number4
StatePublished - Aug 1 1999

Fingerprint

Hemangioma
Tracheotomy
Gas Lasers
Adrenal Cortex Hormones
Intralesional Injections
Laryngoscopy
Respiratory Sounds
Bronchoscopy
Therapeutics
Cough
Intubation
Medical Records
Demography
Morbidity
Safety

Keywords

  • CO laser
  • Congenital subglottic hemangioma
  • Tracheotomy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hughes, C. A., Rezaee, A., Ludemann, J. P., & Holinger, L. D. (1999). Management of congenital subglottic hemangioma. Journal of Otolaryngology, 28(4), 223-228.

Management of congenital subglottic hemangioma. / Hughes, Charles Anthony; Rezaee, Ali; Ludemann, Jeffrey P.; Holinger, Lauren D.

In: Journal of Otolaryngology, Vol. 28, No. 4, 01.08.1999, p. 223-228.

Research output: Contribution to journalArticle

Hughes, CA, Rezaee, A, Ludemann, JP & Holinger, LD 1999, 'Management of congenital subglottic hemangioma', Journal of Otolaryngology, vol. 28, no. 4, pp. 223-228.
Hughes CA, Rezaee A, Ludemann JP, Holinger LD. Management of congenital subglottic hemangioma. Journal of Otolaryngology. 1999 Aug 1;28(4):223-228.
Hughes, Charles Anthony ; Rezaee, Ali ; Ludemann, Jeffrey P. ; Holinger, Lauren D. / Management of congenital subglottic hemangioma. In: Journal of Otolaryngology. 1999 ; Vol. 28, No. 4. pp. 223-228.
@article{90e8941d19f346c38b5c4b8687db37f5,
title = "Management of congenital subglottic hemangioma",
abstract = "Objective: This study was conducted to assess the safety and efficacy of individualized management of congenital subglottic hemangioma (CSH) at the Children's Memorial Hospital in Chicago; describe treatment modalities, including endoscopic excision with the carbon dioxide (CO2) laser, systemic corticosteroids, and intralesional corticosteroid injection with short-term intubation; and determine the success of these various strategies in avoiding tracheotomy. Methods: During the 10-year period between January 1, 1988 and December 31, 1997, 28 infants were diagnosed with CSH. A retrospective review of medical records was undertaken to determine demographics, presenting symptoms, location of the lesion, therapeutic modality, and complications. All patients were contacted at the time of writing. Results: Twenty-eight patients met the criteria for this study. Gender distribution was 1.8:1 female to male. Age at diagnosis ranged from 4 weeks to 8 months, with a mean of 78.8 days and a median of 60 days. The location of CSH was most often posterior and on the left. Associated hemangiomas were found in 14 (50{\%}) cases. The most common symptoms were stridor and cough. Management included 1 to 13 operative direct laryngoscopies and bronchoscopies, endoscopic excision with the (CO2) laser, and the use of systemic and intralesional corticosteroids. No patient required tracheotomy. Conclusion: Morbidity and the need for tracheotomy in CSH patients can be minimized using a combination of therapeutic modalities. Each infant's treatment is individualized based on the severity of the patient's symptoms and the morphology of the lesion.",
keywords = "CO laser, Congenital subglottic hemangioma, Tracheotomy",
author = "Hughes, {Charles Anthony} and Ali Rezaee and Ludemann, {Jeffrey P.} and Holinger, {Lauren D.}",
year = "1999",
month = "8",
day = "1",
language = "English (US)",
volume = "28",
pages = "223--228",
journal = "Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale",
issn = "1916-0208",
publisher = "Decker Publishing",
number = "4",

}

TY - JOUR

T1 - Management of congenital subglottic hemangioma

AU - Hughes, Charles Anthony

AU - Rezaee, Ali

AU - Ludemann, Jeffrey P.

AU - Holinger, Lauren D.

PY - 1999/8/1

Y1 - 1999/8/1

N2 - Objective: This study was conducted to assess the safety and efficacy of individualized management of congenital subglottic hemangioma (CSH) at the Children's Memorial Hospital in Chicago; describe treatment modalities, including endoscopic excision with the carbon dioxide (CO2) laser, systemic corticosteroids, and intralesional corticosteroid injection with short-term intubation; and determine the success of these various strategies in avoiding tracheotomy. Methods: During the 10-year period between January 1, 1988 and December 31, 1997, 28 infants were diagnosed with CSH. A retrospective review of medical records was undertaken to determine demographics, presenting symptoms, location of the lesion, therapeutic modality, and complications. All patients were contacted at the time of writing. Results: Twenty-eight patients met the criteria for this study. Gender distribution was 1.8:1 female to male. Age at diagnosis ranged from 4 weeks to 8 months, with a mean of 78.8 days and a median of 60 days. The location of CSH was most often posterior and on the left. Associated hemangiomas were found in 14 (50%) cases. The most common symptoms were stridor and cough. Management included 1 to 13 operative direct laryngoscopies and bronchoscopies, endoscopic excision with the (CO2) laser, and the use of systemic and intralesional corticosteroids. No patient required tracheotomy. Conclusion: Morbidity and the need for tracheotomy in CSH patients can be minimized using a combination of therapeutic modalities. Each infant's treatment is individualized based on the severity of the patient's symptoms and the morphology of the lesion.

AB - Objective: This study was conducted to assess the safety and efficacy of individualized management of congenital subglottic hemangioma (CSH) at the Children's Memorial Hospital in Chicago; describe treatment modalities, including endoscopic excision with the carbon dioxide (CO2) laser, systemic corticosteroids, and intralesional corticosteroid injection with short-term intubation; and determine the success of these various strategies in avoiding tracheotomy. Methods: During the 10-year period between January 1, 1988 and December 31, 1997, 28 infants were diagnosed with CSH. A retrospective review of medical records was undertaken to determine demographics, presenting symptoms, location of the lesion, therapeutic modality, and complications. All patients were contacted at the time of writing. Results: Twenty-eight patients met the criteria for this study. Gender distribution was 1.8:1 female to male. Age at diagnosis ranged from 4 weeks to 8 months, with a mean of 78.8 days and a median of 60 days. The location of CSH was most often posterior and on the left. Associated hemangiomas were found in 14 (50%) cases. The most common symptoms were stridor and cough. Management included 1 to 13 operative direct laryngoscopies and bronchoscopies, endoscopic excision with the (CO2) laser, and the use of systemic and intralesional corticosteroids. No patient required tracheotomy. Conclusion: Morbidity and the need for tracheotomy in CSH patients can be minimized using a combination of therapeutic modalities. Each infant's treatment is individualized based on the severity of the patient's symptoms and the morphology of the lesion.

KW - CO laser

KW - Congenital subglottic hemangioma

KW - Tracheotomy

UR - http://www.scopus.com/inward/record.url?scp=0032867516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032867516&partnerID=8YFLogxK

M3 - Article

C2 - 10461260

AN - SCOPUS:0032867516

VL - 28

SP - 223

EP - 228

JO - Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale

JF - Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale

SN - 1916-0208

IS - 4

ER -